RadNet Net Income/Loss 2010-2024 | RDNT
RadNet net income/loss from 2010 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
RadNet Annual Net Income/Loss
(Millions of US $) |
| 2024 |
$39 |
| 2023 |
$30 |
| 2022 |
$34 |
| 2021 |
$44 |
| 2020 |
$-2 |
| 2019 |
$23 |
| 2018 |
$38 |
| 2017 |
$2 |
| 2016 |
$8 |
| 2015 |
$9 |
| 2014 |
$2 |
| 2013 |
$2 |
| 2012 |
$60 |
| 2011 |
$7 |
| 2010 |
$-13 |
| 2009 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$4.587B |
$1.830B |
|
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
|
